1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow ZED1227: new trials by email Literature Review of ZED1227 trials Research Report on ZED1227
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease ZED1227 + SIGE, Placebo - Celiac Disease | Phase 2 | Recruiting | Dr. Falk Pharma GmbH | 356 | 2024-06-10 | 2026-04-02 |
| Different Doses of ZED1227 vs. Placebo in NAFLD ZED1227, Placebo - NAFLD, Liver Fibrosis | Phase 2 | Completed | Dr. Falk Pharma GmbH | 186 | 2022-04-19 | 2024-05-14 |
Celiac Disease (1) · Liver Cirrhosis (1) · Non-alcoholic Fatty Liver Disease (1)
Germany (2)
2023 (1)